Delayed treatment effects of xanthine oxidase inhibition on systolic overload-induced left ventricular hypertrophy and dysfunction

Nucleosides, Nucleotides and Nucleic Acids

Volumn 29, Issue 4-6, 2010, Pages 306-313

  Xu, X ^a   Zhao, L ^b   Hu, X ^a   Zhang, P ^a   Wessale, J ^b   Bache, R ^a   Chen, Y ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b TAKEDA PHARMACEUTICALS   (United States)

Author keywords

allopurinol; Febuxostat; heart failure; left ventricular dysfunction

Indexed keywords

ALLOPURINOL; DRINKING WATER; FEBUXOSTAT; URIC ACID; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; C57BL 6 MOUSE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE OVERLOAD; HISTOPATHOLOGY; MALE; MORTALITY; MOUSE; NONHUMAN; SYSTOLE; THERAPY DELAY; TREATMENT DURATION; URIC ACID BLOOD LEVEL;

ALLOPURINOL; ANIMALS; CONSTRICTION, PATHOLOGIC; ENZYME INHIBITORS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MICE; MICE, INBRED C57BL; THIAZOLES; XANTHINE OXIDASE;

MUS;

EID: 77953722261     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257771003738683     Document Type: Article

References (12)

1. Ekelund, U.E.; Harrison, R.W.; Shokek, O.; Thakkar, R.N.; Tunin, R.S.; Senzaki, H.; Kass, D.A.; Marb́an, E.; Hare, J.M. Intravenous allopurinol decreases myocardial oxygen consumption and increasesmechanical efficiency in dogs with pacing-induced heart failure. Circ. Res. 1999, 85, 437-445.
2. Cappola, T.P.; Kass, D.A.; Nelson, G.S.; Berger, R.D.; Rosas, G.O.; Kobeissi, Z.A.; Marb́an, E.; Hare, J.M. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation. 2001, 104, 2407-2411.
3. Amado, L.C.; Saliaris, A.P.; Raju, S.V.; Lehrke, S.; St John, M.; Xie, J.; Stewart, G.; Fitton, T.; Minhas, K.M.; Brawn, J.; Hare, J.M. Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure. J. Mol. Cell. Cardiol. 2005, 39, 531-536.
4. Stull, L.B.; Leppo, M.K.; Szweda, L.; Gao, W.D.; Marban, E. Chronic treatment with allopurinol boosts survival and cardiac contractility in murine postischemic cardiomyopathy. Circ. Res. 2004, 12, 1005-1011.
5. Engberding, N.; Spiekermann, S.; Schaefer, A.; Heineke, A.; Wiencke, A.; Muller, M.; Fuchs, M.; Hilfiker-Kleiner, D.; Hornig, B.; Drexler, H.; Landmesser, U. Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug? Circulation. 2004, 12, 2175-2179.
6. Naumova, A.V.; Chacko, V.P.; Ouwerkerk, R.; Stull, L.; Marban, E.; Weiss, R.G. Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts. Am. J. Physiol. 2006, 290, H837-H843.
7. Xu, X.; Hu, X.; Lu, Z.; Zhang, P.; Zhao, L.; Wessale, J.L.; Bache, R.J.; Chen, Y. Xanthine oxidase inhibition with febuxostat attenuates systolic overload-induced left ventricular hypertrophy and dysfunction in mice. J. Card. Fail. 2008, 14, 746-753.
8. Lu, Z.; Fassett, J.; Xu, X.; Hu, X.; Zhu, G.; French, J.; Zhang, P.; Schnermann, J.; Bache, R.J.; Chen, Y. Adenosine A3 receptor deficiency exerts unanticipated protective effects on the pressure-overloaded left ventricle. Circulation. 2008, 118, 1713-1721.
9. Zhang, P.; Xu, X.; Hu, X.; van Deel, E.D.; Zhu, G.; Chen, Y. Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure. Circ Res. 2007, 100, 1089-1098.
10. Zhao, L.; Roche, B.M.; Wessale, J.L.; Kijtawornrat, A.; Lolly, J.L.; Shemanski, D.; Hamlin, R.L. Chronic xanthine oxidase inhibition following myocardial infarction in rabbits: effects of early versus delayed treatment. Life. Sci. 2008, 82, 495-502.
11. Takano, Y.; Hase-Ayoki, K.; Horiuchi, H.; Zhao, L.; Kasahara, Y.; Knodo, S.; Becker, M.A. Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase. Life. Sci. 2005, 76, 1835-1847.
12. Okamoto, K.; Eger, B.T.; Nishino, T.; Kondo, S.; Pai, E.F.; Nishino, T. An extremely potent inhibitor of xanthine oxidoreductase: Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition. J. Biol. Chem. 2003, 278, 1848-1855.